Drugs / Cabazitaxel-XRP6258
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01438307 | Sep 2011 → Sep 2014 | non-small cell lung carcinoma | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cabazitaxel-XRP6258 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01438307 ↗ |
| Route | Intravenous | “as a 1 hour IV infusion” NCT01438307 ↗ |